Aurisco Pharmaceutical Co.,Ltd.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Rok finansowy 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025 2025 2025
Kwartał Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3
Data 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31 2025-06-30 2025-09-30
Przychód (mln) 151 144 181 202 161 178 186 215 187 214 219 290 260 239 302 251 370 340 336 395 358 387 402 420 415
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 6.9% 23.4% 3.1% 6.7% 16.4% 20.5% 17.4% 34.7% 38.8% 11.6% 38.1% -13.65% 42.2% 42.2% 11.1% 57.7% -3.30% 13.9% 19.8% 6.3% 16.1%
Marża brutto 51.6% 57.1% 50.3% 49.7% 52.3% 36.8% 42.8% 49.1% 55.4% 49.2% 55.7% 48.3% 46.4% 57.6% 45.6% 54.9% 64.4% 56.7% 53.7% 59.9% 60.7% 54.4% 60.7% 59.5% 62.5%
Koszty i Wydatki (mln) 105 104 124 139 115 144 143 160 132 176 165 209 207 199 238 203 252 272 235 278 249 303 260 294 274
EBIT (mln) 55 32 59 64 41 24 40 58 57 38 53 94 25 26 59 59 147 65 100 117 109 84 142 126 141
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% -25.53% -26.63% -31.78% -8.77% 39.4% 62.4% 32.1% 61.8% -55.47% -33.40% 10.4% -37.26% 484.0% 155.7% 70.3% 98.6% -26.37% 29.1% 40.9% 7.7% 29.7%
EBIT (%) 36.3% 22.4% 32.8% 31.5% 25.3% 13.3% 21.7% 27.0% 30.3% 17.9% 24.4% 32.4% 9.7% 10.7% 19.5% 23.5% 39.8% 19.2% 29.9% 29.6% 30.3% 21.8% 35.2% 30.0% 33.9%
Przychody finansowe (mln) -0 3 -0 -0 -1 7 -1 4 -6 11 -1 4 -6 8 -1 3 -5 20 8 3 4 3 4 6 7
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 2 31 -2 1 1 0 1 1 0 5 10 8 9 9
Amortyzacja (mln) 2 7 7 8 7 8 12 12 16 16 18 18 18 18 20 20 21 21 19 20 18 20 20 24 0
EBITDA (mln) 41 45 58 61 42 39 44 54 55 39 53 84 56 62 60 59 151 76 107 129 134 95 162 146 145
EBITDA(%) 27.3% 31.0% 32.2% 30.3% 26.2% 21.8% 23.7% 24.9% 29.5% 18.0% 24.4% 29.1% 21.5% 25.8% 20.0% 23.5% 40.8% 22.3% 31.9% 32.8% 37.5% 24.5% 40.4% 34.7% 35.0%
NOPLAT (mln) 53 69 59 63 41 24 40 58 56 38 53 94 68 26 59 59 147 64 99 117 108 83 142 126 137
Podatek (mln) 5 3 9 10 3 7 8 8 5 3 13 18 -1 3 13 8 11 8 17 11 13 12 22 11 18
Zysk Netto (mln) 48 66 50 53 37 17 33 50 51 35 41 76 70 25 46 50 137 57 82 106 95 71 119 115 119
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% -22.36% -74.31% -34.86% -5.00% 36.1% 106.8% 25.4% 50.6% 37.8% -30.39% 12.3% -34.09% 96.2% 132.1% 79.1% 112.7% -30.33% 24.8% 45.3% 8.5% 24.6%
Zysk netto (%) 31.8% 46.0% 27.7% 26.3% 23.1% 9.6% 17.5% 23.4% 27.0% 16.4% 18.7% 26.2% 26.8% 10.2% 15.2% 20.0% 36.9% 16.7% 24.5% 26.9% 26.6% 18.3% 29.7% 27.5% 28.6%
EPS 0.13 0.18 0.14 0.15 0.1 0.0458 0.08 0.12 0.12 0.09 0.1 0.19 0.17 0.0611 0.11 0.12 0.34 0.47 0.2 0.2647 0.2368 0.178 0.3 0.29 0.29
EPS (rozwodnione) 0.13 0.18 0.14 0.15 0.1 0.0458 0.08 0.12 0.12 0.09 0.1 0.19 0.17 0.0611 0.11 0.12 0.34 0.47 0.2 0.2647 0.2368 0.178 0.3 0.29 0.29
Ilość akcji (mln) 368 368 357 354 368 371 401 401 401 393 401 397 401 401 401 401 401 416 411 402 402 398 398 398 402
Ważona ilość akcji (mln) 368 368 357 357 371 371 407 407 407 393 409 409 409 401 401 401 401 416 411 402 402 398 398 398 402
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY